Moreover, IF showed that the number of NR2F1+ dormant cells in mice treated with tozasertib increased significantly (Fig. 9j), while the positive rate of Ki-67 in tumor cells decreased (Fig. 9k). The gene discussed is NR2F1; the disease is neoplasm.